Why the study?
Does adding dihydroergotamine to low-dose heparin prevent thromboembolic complications in patients who have undergone major abdominal surgery?
Population
181 patients who underwent major abdominal surgery
Comparison
Dihydroergotamine mesylate administered with… vs Low-dose heparin sodium given alone
Design
RCT, randomized
Loading...
Adding dihydroergotamine to low-dose heparin offers no thromboembolism benefit; supports heparin monotherapy after major abdominal surgery.
Does adding dihydroergotamine to low-dose heparin prevent thromboembolic complications in patients who have undergone major abdominal surgery?
Adding dihydroergotamine to low-dose heparin provides no significant clinical advantage in preventing thromboembolic complications after major abdominal surgery.
A 1983 study studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: